Purpose: To report a case of intraocular medulloepithelioma, an embryonal tumour with extremely rare presentation in adults.

Method: The case of a 44-year-old man with intraocular malignant teratoid medulloepithelioma, primarily diagnosed as intraocular teratoma, is described and the literature on this subject is reviewed.

Results: The patient presented with progressive proptosis caused by a tumour in the left eyeball. He had a 28-year history of loss of vision in the left eye. Histopathological examination of the enucleated eye demonstrated an intraocular teratoma. No adjuvant treatment was given. Six months later the patient presented with massive progression in the left orbit and intracranial invasion. Cisplatin-based chemotherapy was administered, but discontinued after two cycles due to poor tolerance and lack of response. At subsequent pathology review, a final diagnosis of malignant teratoid medulloepithelioma was made. Salvage radiotherapy (60 Gy in 30 fractions) resulted in partial response of the intracranial lesion. However, the patient died 6 months later due to intracranial tumour progression.

Conclusion: Medulloepithelioma should be considered in the differential diagnosis of intraocular tumours in adults, especially in the case of coexisting, long-standing ocular symptoms. In some cases this disease is very aggressive.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0420.2005.00586.xDOI Listing

Publication Analysis

Top Keywords

malignant teratoid
12
teratoid medulloepithelioma
12
intraocular malignant
8
intraocular teratoma
8
patient presented
8
intraocular
6
medulloepithelioma
5
medulloepithelioma adult
4
adult clinicopathological
4
case
4

Similar Publications

Atypical teratoid/rhabdoid tumors (AT/RTs) of the central nervous system (CNS) are rare and aggressive, typically occurring in early childhood or infancy, with adult cases being extremely rare. These tumors are associated with the inactivation of the integrase interactor 1 (INI1) gene. The prognosis is poor, worsening significantly if metastasis is detected at diagnosis.

View Article and Find Full Text PDF

Designing a Time-Dependent Therapeutic Strategy using CDK4/6 Inhibitors in an Intracranial ATRT Model.

Neuro Oncol

December 2024

Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA.

Background: Inhibitors targeting cyclin-dependent kinases 4 and 6 (CDK4/6), crucial for cell cycle regulation, have shown promise in early-stage studies for treating central nervous system (CNS) tumors. However, challenges such as limited CNS penetration, optimal treatment duration, and systemic side effects have impeded their clinical translation for pediatric brain tumors (PBTs).

Methods: We evaluated the potency of CDK4/6 inhibitors across various PBTs cell lines, focusing particularly on palbociclib against atypical teratoid rhabdoid tumor (ATRT) with cell viability assays and gene expression analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Atypical teratoid/rhabdoid tumor (AT/RT) is a rare brain cancer mainly found in children, but can appear in adults, especially in the sellar region of middle-aged women.
  • A case study is presented of a 51-year-old woman with AT/RT who had headaches and left ptosis, leading to a diagnosis and treatment that included surgery, radiation, and chemotherapy.
  • Despite treatment, the patient developed lung metastases and passed away seven months post-diagnosis, highlighting the need for further awareness of AT/RT in adults, particularly when considering sellar masses.
View Article and Find Full Text PDF

Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors.

Genome Biol

December 2024

Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany.

Background: Atypical teratoid rhabdoid tumors (ATRT) are incurable high-grade pediatric brain tumors. Despite intensive research efforts, the prognosis for ATRT patients under currently established treatment protocols is poor. While novel therapeutic strategies are urgently needed, the generation of molecular-driven treatment concepts is a challenge mainly due to the absence of actionable genetic alterations.

View Article and Find Full Text PDF

Differential Replication and Oncolytic Effects of Zika Virus in Aggressive CNS Tumor Cells: Insights from Organoid and Tumoroid Models.

Viruses

November 2024

Human Genome and Stem Cell Research Center (CEGH-CEL), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, Cidade Universitária, São Paulo 05508-090, SP, Brazil.

Article Synopsis
  • CNS cancers like Glioblastoma and pediatric tumors face significant treatment challenges due to their poor response to conventional therapies such as radiation and chemotherapy.* -
  • Recent research highlights the potential of the Zika virus (ZIKV) as an oncolytic treatment, showing its ability to infect and kill malignant CNS tumor cells while having a preference for tumor rather than normal cells.* -
  • Experiments using hybrid co-culture models demonstrated that ZIKV replication was enhanced in tumor cells compared to normal cells, leading to notable reductions in the number of certain tumor types, although not uniformly effective across all cancers.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!